Small Molecules

03 Jul 2007 Spectrum Pharmaceuticals Completes the NDA Filing for ISO-Vorin(TM)
03 Jul 2007 LEO Pharma Submits MAA for Daivobet(R) Scalp gel
03 Jul 2007 Kyoto University and Astellas Co-research at the Innovation Center for Immunoregulation Technologies and Drugs of Next Generation
03 Jul 2007 Portola Pharmaceuticals Announces Positive Phase II EXPERT Results and Additional Oral and Poster Presentations at the XXI Congress of the International Society on Thrombosis and Haemostasis (ISTH)
02 Jul 2007 NicOx SA Initiates Third Pivotal Naproxcinod Phase 3 Study
30 Jun 2007 Rimonabant Regulatory Update in the United States
30 Jun 2007 Cyclacel Pharmaceuticals initiates Phase I study of CYC116 in patients with advanced solid tumors
30 Jun 2007 Keryx Biopharmaceuticals, Inc. Announces Positive Phase I and Phase II Data on KRX-0401 in Patients with Relapsed/Refractory Multiple Myeloma and Waldenstrom's Macroglobulinemia
30 Jun 2007 Akorn, Inc. Announces the New Drug Application Filing for Akten(R)
30 Jun 2007 Algeta Begins Clinical Dosimetry Study with Alpharadin in Prostate Cancer Patients
29 Jun 2007 Alteon Initiates Phase 2 Trial of ALT-2074 in Diabetes and Haptoglobin 2-2
29 Jun 2007 CombinatoRx Product Candidate CRx-150 Shows Activity on DAS28 and Pain, but Not CRP
29 Jun 2007 INVEGA(TM) Receives Marketing Authorization In European Union For Treatment Of Schizophrenia
29 Jun 2007 Pfizer Initiates Phase III Trial to Study Sunitinib Malate in Patients with Metastatic Colorectal Cancer
29 Jun 2007 Surface Logix Commences Phase 2a Clinical Trial of SLx-2101 in Raynaud's Disease
29 Jun 2007 Cytochroma reports positive Phase I clinical data for CTA018 injection
29 Jun 2007 Progenics and Wyeth Announce Positive Results from Three-Month Clinical-Extension Study of Subcutaneous Methylnaltrexone for the Treatment of Opioid-Induced Constipation in Patients with Advanced Illness
29 Jun 2007 4SC AG: patient recruitment successfully completed for phase IIa clinical trial
29 Jun 2007 Accentia Biopharmaceuticals Announces Favorable Interim Blinded Data on SinuNase in Its Fast-Tracked Pivotal Phase 3 Clinical Trial for Chronic Sinusitis
29 Jun 2007 ZIO-101 (Darinaparsin) Interim Phase II and Preclinical Data Presented at International Myeloma Workshop
29 Jun 2007 Biotie Therapies corp. stock exchange release
29 Jun 2007 VELCADE(R) (Bortezomib) for Injection Based Therapies Achieved Survival Rates as High as 100 Percent in Newly Diagnosed Multiple Myeloma Patients
29 Jun 2007 Speedel reports successful SPP635 Phase IIa trial in hypertension
29 Jun 2007 Cytokinetics Reports Additional Clinical Trials Data for Ispinesib
29 Jun 2007 Cylene Pharmaceuticals' Ribosomal RNA Biogenesis Inhibitor, Quarfloxin (CX-3543), Enters Phase II Clinical Trial

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2019 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up